[Kuaishou (1024 HK, BUY, TP HK$75) Preview]: C3Q24 Preview: Solid Growth and Faster Growth Ahead
Kuaishou's C3Q24 results meet expectations with strong advertising but slower GMV growth, prompting analysts to maintain a BUY rating with a...
127 Views
2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher
Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.
568 Views
Tencent Investee Selldown - The US$120bn Global Overhang
There have been multiple reports that Tencent (700 HK) plans to trim its investment portfolio over the remainder of the year. We look at Tencent's...
610 Views
Kuaishou Placement - US$480m Secondary Block Deal a Small One to Digest
DCM Investments is looking to raise US$484m via selling its remaining stake in Kuaishou Technology (1024 HK). In this note, we run the deal through...
598 Views
HSI, HSCEI, HSTECH, HSIII: Rebalance Flows Post Capping (Sep 2024)
The September rebalance of the HSI, HSCEI, HSTECH and HSIII indices will use today's closing prices for capping. The round-trip trade across the...
542 Views